Vie Ventures is a firm dedicated to bridging venture capital with disease-focused philanthropy to accelerate transformative therapies for autoimmune disease.
We invest in emerging therapeutics for autoimmune and immune-mediated diseases, an area of high unmet medical need and growing scientific opportunity. Our focus is primarily on Series B and C-stage biotech companies, where thoughtful capital and strategic collaboration can meaningfully accelerate progress.
Vie works in close partnership with leading disease foundations including the Crohn’s & Colitis Foundation, Lupus Research Alliance, National MS Society, Scleroderma Research Foundation, Sjogren's Foundation and others to align investment decisions with patient needs and scientific insight.
Our goal is to help translate promising science into approved therapies, advancing both patient outcomes and investor returns.
Company Details
- Employees
- 6
- Founded
- 2025
- Address
- Cambridge , Ma 02142, Us
- Industry
- Financial Services
- NAICS
-
Finance and InsuranceMonetary Authorities-Central Bank
- Website
- https://vieventures.com
- Keywords
- Cambridge.
- HQ
- Cambridge , Ma
Vie Ventures Questions
Vie Ventures's website is https://vieventures.com
Vie Ventures's LinkedIn profile is https://www.linkedin.com/company/vie-ventures
Vie Ventures has
6 employees.
View email and phone details for 6
employees at Vie Ventures.
Vie Ventures's industry is
Financial Services
Vie Ventures's top competitors are
Lupus Research Alliance,
Mpm Bioimpact,
Vie Ventures,
Sjögren’s Foundation,
T1d Fund,
Scleroderma Research Foundation,
P74 Ventures,
Crohn's & Colitis Foundation,
Actithera,
Verona Pharma.
Vie Ventures's categories are Financial Services
Vie Ventures's founding year is 2025
